Salvatore Lococo

The University of Texas Southwestern Medical Center

Papers

2

Total Citations

32

H-Index

2

About

Salvatore Lococo is a leading figure in gynecologic oncology, whose research has fundamentally shaped the surgical management of early-stage cervical cancer. His primary focus lies in evaluating the comparative effectiveness and safety of robotic versus open radical hysterectomy, a critical area of debate following the landmark LACC trial. Dr. Lococo is the principal investigator of the pivotal ROCC/GOG-3043 trial, a randomized non-inferiority study that directly challenges previous findings by comparing robotic surgery to the open approach. His most cited work (2022, 24 citations) establishes the trial’s critical background, while his subsequent 2025 publication (8 citations) provides updated, practice-informing results. By rigorously assessing oncologic outcomes and perioperative safety, Dr. Lococo’s contributions provide high-level evidence that helps surgeons and patients navigate the complex choice between minimally invasive and open techniques. His work is essential reading for any researcher or clinician seeking to understand the evolving landscape of cervical cancer surgery and the role of robotics in improving patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
32
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
ROCC/GOG-3043: A randomized non-inferiority trial of robotic versus open radical hysterectomy for early-stage cervical cancer.
24 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago